Tapewire

NYSE · USD

COR

Cencora, Inc.

Export transactions ↓
Tapewire entity
2994
SEC CIK
0001140859
Parsed reports
801

Last 12 months

Inside the activity.

3 purchase rows · 12 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202504
Jan 202601
Feb 202602
Mar 202600
Apr 202600
May 202610
Jun 202620
Jul 202600
Aug 202601
Sep 202602
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 22, 2024 Filed Oct 23, 2024 20:06 UTC
COLLIS STEVEN HDirector · Executive Chairman
Exercise / conversionCommon Stock 21,509 $89.58 $1,926,776.22
Disclosure

SEC source: 0001140859-24-000137 · wk-form4_1729713970.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 306,597

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 17, 2024 Filed Sep 18, 2024 20:37 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 21,509 $0.00 Strike: $89.58 $0.00
Disclosure

SEC source: 0001140859-24-000133 · wk-form4_1726691838.xml · derivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,018

Underlying: Common Stock · 21,509 shares

Expires 2025-11-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal installments on 11/14/19, 11/14/20, 11/14/21 and 11/14/22.

Read SEC document
September 17, 2024 Filed Sep 18, 2024 20:37 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 21,509 $241.01 $5,183,884.09
Disclosure

SEC source: 0001140859-24-000133 · wk-form4_1726691838.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 285,088

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/18/23 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 12/21/23.

Read SEC document
September 17, 2024 Filed Sep 18, 2024 20:37 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 21,509 $89.58 $1,926,776.22
Disclosure

SEC source: 0001140859-24-000133 · wk-form4_1726691838.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 306,597

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 20, 2024 Filed Aug 21, 2024 20:08 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 10,754 $0.00 Strike: $89.58 $0.00
Disclosure

SEC source: 0001140859-24-000131 · wk-form4_1724270896.xml · derivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,527

Underlying: Common Stock · 10,754 shares

Expires 2025-11-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal installments on 11/14/19, 11/14/20, 11/14/21 and 11/14/22.

Read SEC document
August 20, 2024 Filed Aug 21, 2024 20:08 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 10,754 $239.13 $2,571,604.02
Disclosure

SEC source: 0001140859-24-000131 · wk-form4_1724270896.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 285,088

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/18/23 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 12/21/23.

Read SEC document
August 20, 2024 Filed Aug 21, 2024 20:08 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 10,754 $89.58 $963,343.32
Disclosure

SEC source: 0001140859-24-000131 · wk-form4_1724270896.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 295,842

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 06, 2024 Filed Aug 7, 2024 20:09 UTC
Battaglia SilvanaExecutive Vice President
SaleCommon Stock 1,473 $242.69 $357,482.37
Disclosure

SEC source: 0001140859-24-000127 · wk-form4_1723061367.xml · nonDerivative · entry 1

Battaglia Silvana · CIK 0001774724 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,948.08

Read SEC document
August 05, 2024 Filed Aug 7, 2024 20:11 UTC GiftCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001140859-24-000129 · wk-form4_1723061477.xml · nonDerivative · entry 1

GREENBERG LON R · CIK 0001234234 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,062

F1 · kind: Gift to charitable trust.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 22:44 UTC SaleCommon Stock 4,438,171 $240.56 $1,067,646,415.76
Disclosure

SEC source: 0000950170-24-091058 · ownership.xml · nonDerivative · entry 1

Walgreens Boots Alliance, Inc. · CIK 0001618921 · 10% owner

Walgreens Boots Alliance Holdings LLC · CIK 0001669077 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 19,980,000

F4 · kind: Represents a sale pursuant to Rule 144 (3,398,929 shares) and a sale in a private transaction to the Issuer (1,039,242 shares), in each case, by WBA Holdings.

F1 · balance_after: As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 14, 2016, January 6, 2021, June 3, 2021, May 12, 2022, August 4, 2022, November 9, 2022, December 12, 2022, May 15, 2023, June 20, 2023, August 7, 2023, November 14, 2023, February 9, 2024 and August 5, 2024 (the "Schedule 13D"), the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by the Reporting Person on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement").

F1 · ownership.nature: As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 14, 2016, January 6, 2021, June 3, 2021, May 12, 2022, August 4, 2022, November 9, 2022, December 12, 2022, May 15, 2023, June 20, 2023, August 7, 2023, November 14, 2023, February 9, 2024 and August 5, 2024 (the "Schedule 13D"), the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by the Reporting Person on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement").

F2 · ownership.nature: These shares were held by Walgreens Boots Alliance Holdings LLC ("WBA Holdings"), an indirect wholly owned subsidiary of the Reporting Person.

F3 · ownership.nature: As described in the Schedule 13D, WBA Investments, Inc., a direct wholly-owned subsidiary of the Reporting Person and the sole member of WBA Holdings, may also be deemed to beneficially own the securities reported in this Form 4.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 20:11 UTC GrantCommon Stock 128 $244.46 $31,290.88
Disclosure

SEC source: 0001140859-24-000125 · wk-form4_1722888687.xml · nonDerivative · entry 1

NALLY DENNIS M · CIK 0001685596 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,084

F1 · shares: Shares of common stock issued in lieu of $31,250 quarterly cash retainer per the terms of the Registrant's Non-Employee Director Compensation Program.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 20:10 UTC GrantCommon Stock 103 $244.46 $25,179.38
Disclosure

SEC source: 0001140859-24-000123 · wk-form4_1722888604.xml · nonDerivative · entry 1

Baumann Werner · CIK 0001986505 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,776

F1 · shares: Grant of Restricted Stock Units received in lieu of $25,000 quarterly cash retainer per the Registrant's Non-Employee Director Compensation Program. Delivery of shares deferred until 01/15/2028.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 20:08 UTC GrantCommon Stock 103 $244.46 $25,179.38
Disclosure

SEC source: 0001140859-24-000121 · wk-form4_1722888513.xml · nonDerivative · entry 1

Tyler Lauren M · CIK 0001765744 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,776

F1 · shares: Grant of Restricted Stock Units received in lieu of $25,000 quarterly cash retainer per the Registrant's Non-Employee Director Compensation Program. Delivery of vested shares deferred until 03/01/2025.

Read SEC document
July 16, 2024 Filed Jul 17, 2024 20:09 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 10,755 $0.00 Strike: $89.58 $0.00
Disclosure

SEC source: 0001140859-24-000113 · wk-form4_1721246984.xml · derivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,281

Underlying: Common Stock · 10,755 shares

Expires 2025-11-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal installments on 11/14/19, 11/14/20, 11/14/21 and 11/14/22.

Read SEC document
July 16, 2024 Filed Jul 17, 2024 20:09 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 10,755 $222.12 $2,388,900.60
Disclosure

SEC source: 0001140859-24-000113 · wk-form4_1721246984.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 285,088

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/18/2023 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 12/21/2023.

Read SEC document
July 16, 2024 Filed Jul 17, 2024 20:09 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 10,755 $89.58 $963,432.90
Disclosure

SEC source: 0001140859-24-000113 · wk-form4_1721246984.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 295,843

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:08 UTC
Donato Leslie EEVP & Chief Strategy Officer
Exercise / conversionRestricted Stock Units · Derivative 1,432 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001140859-24-000105 · wk-form4_1719950905.xml · derivative · entry 3

Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,432 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024.

F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024.

F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:08 UTC
Donato Leslie EEVP & Chief Strategy Officer
Tax withholdingCommon Stock 533 $233.53 $124,471.49
Disclosure

SEC source: 0001140859-24-000105 · wk-form4_1719950905.xml · nonDerivative · entry 2

Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,457.849

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:08 UTC
Donato Leslie EEVP & Chief Strategy Officer
Exercise / conversionCommon Stock 1,432 $0.00 $0.00
Disclosure

SEC source: 0001140859-24-000105 · wk-form4_1719950905.xml · nonDerivative · entry 1

Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,990.849

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024.

Read SEC document
June 28, 2024 Filed Jul 5, 2024 20:17 UTC
Battaglia SilvanaExecutive Vice President
GrantCommon Stock 66.277 $191.51 $12,692.38
Disclosure

SEC source: 0001140859-24-000111 · wk-form4_1720210645.xml · nonDerivative · entry 1

Battaglia Silvana · CIK 0001774724 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,421.08

F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c).

Read SEC document
June 28, 2024 Filed Jul 5, 2024 20:15 UTC
Campbell Elizabeth SExecutive Vice President
GrantCommon Stock 57.902 $191.51 $11,088.52
Disclosure

SEC source: 0001140859-24-000109 · wk-form4_1720210553.xml · nonDerivative · entry 1

Campbell Elizabeth S · CIK 0001882641 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,304.322

F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c).

Read SEC document
June 28, 2024 Filed Jul 5, 2024 20:13 UTC
Donato Leslie EEVP & Chief Strategy Officer
GrantCommon Stock 66.879 $191.51 $12,807.66
Disclosure

SEC source: 0001140859-24-000107 · wk-form4_1720210429.xml · nonDerivative · entry 1

Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,524.728

F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c).

Read SEC document
June 18, 2024 Filed Jun 20, 2024 20:16 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 10,754 $0.00 Strike: $89.58 $0.00
Disclosure

SEC source: 0001140859-24-000103 · wk-form4_1718914557.xml · derivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,036

Underlying: Common Stock · 10,754 shares

Expires 2025-11-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal installments on 11/14/19, 11/14/20, 11/14/21 and 11/14/22.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 20:16 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 10,754 $235.76 $2,535,363.04
Disclosure

SEC source: 0001140859-24-000103 · wk-form4_1718914557.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 285,088

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/18/2023 and disclosed in the Company's Form 8-K filed with the Securities and Exchange Commission on 12/21/2023.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 20:16 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 10,754 $89.58 $963,343.32
Disclosure

SEC source: 0001140859-24-000103 · wk-form4_1718914557.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 295,842

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 31, 2024 Filed Jun 3, 2024 20:05 UTC
Clark GinaExecutive Vice President
SaleCommon Stock 1,874 $223.86 $419,506.14
Disclosure

SEC source: 0001140859-24-000097 · wk-form4_1717445143.xml · nonDerivative · entry 1

Clark Gina · CIK 0001625811 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,284

Read SEC document
May 29, 2024 Filed May 31, 2024 20:00 UTC
Clark GinaExecutive Vice President
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 27,093 $0.00 Strike: $86.09 $0.00
Disclosure

SEC source: 0001140859-24-000095 · wk-form4_1717185637.xml · derivative · entry 4

Clark Gina · CIK 0001625811 · Executive Vice President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 27,093 shares

Expires 2026-11-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Exercisable in four equal installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23.

Read SEC document
May 29, 2024 Filed May 31, 2024 20:00 UTC
Clark GinaExecutive Vice President
SaleCommon Stock 27,093 $216.07 $5,853,984.51
Disclosure

SEC source: 0001140859-24-000095 · wk-form4_1717185637.xml · nonDerivative · entry 3

Clark Gina · CIK 0001625811 · Executive Vice President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,158

F2 · price: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $216.00 to $216.14, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.

Read SEC document
May 29, 2024 Filed May 31, 2024 20:00 UTC
Clark GinaExecutive Vice President
Exercise / conversionCommon Stock 27,093 $86.09 $2,332,436.37
Disclosure

SEC source: 0001140859-24-000095 · wk-form4_1717185637.xml · nonDerivative · entry 2

Clark Gina · CIK 0001625811 · Executive Vice President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,251

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2024 Filed May 29, 2024 20:02 UTC PurchaseCommon Stock 500 $218.58 $109,290.00
Disclosure

SEC source: 0001140859-24-000088 · wk-form4_1717012937.xml · nonDerivative · entry 1

DURCAN DERMOT MARK · CIK 0001202358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,876

Read SEC document
May 22, 2024 Filed May 24, 2024 20:05 UTC SaleCommon Stock 1,859,390 $215.12 $400,000,158.12
Disclosure

SEC source: 0000950170-24-064553 · ownership.xml · nonDerivative · entry 1

Walgreens Boots Alliance, Inc. · CIK 0001618921 · 10% owner

Walgreens Boots Alliance Holdings LLC · CIK 0001669077 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 24,418,171

F4 · kind: Represents a sale in a private transaction to the Issuer (1,859,390 shares) by WBA Holdings.

F1 · balance_after: As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 14, 2016, January 6, 2021, June 3, 2021, May 12, 2022, August 4, 2022, November 9, 2022, December 12, 2022, May 15, 2023, June 20, 2023, August 7, 2023, November 14, 2023 and February 9, 2024 (the "Schedule 13D"), the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by the Reporting Person on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement").

F1 · ownership.nature: As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 14, 2016, January 6, 2021, June 3, 2021, May 12, 2022, August 4, 2022, November 9, 2022, December 12, 2022, May 15, 2023, June 20, 2023, August 7, 2023, November 14, 2023 and February 9, 2024 (the "Schedule 13D"), the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by the Reporting Person on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement").

F2 · ownership.nature: These shares were held by Walgreens Boots Alliance Holdings LLC ("WBA Holdings"), an indirect wholly owned subsidiary of the Reporting Person.

F3 · ownership.nature: As described in the Schedule 13D, WBA Investments, Inc., a direct wholly-owned subsidiary of the Reporting Person and the sole member of WBA Holdings, may also be deemed to beneficially own the securities reported in this Form 4.

Read SEC document
May 21, 2024 Filed May 22, 2024 20:08 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 10,755 $0.00 Strike: $89.58 $0.00
Disclosure

SEC source: 0001140859-24-000085 · wk-form4_1716408514.xml · derivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 96,790

Underlying: Common Stock · 10,755 shares

Expires 2025-11-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal installments on 11/14/19, 11/14/20, 11/14/21 and 11/14/22.

Read SEC document
May 21, 2024 Filed May 22, 2024 20:08 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 10,755 $221.30 $2,380,081.50
Disclosure

SEC source: 0001140859-24-000085 · wk-form4_1716408514.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 285,088

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/18/2023 and disclosed in the Company's Form 8-K filed with the Securities and Exchange Commission on 12/21/2023.

Read SEC document
May 21, 2024 Filed May 22, 2024 20:08 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 10,755 $89.58 $963,432.90
Disclosure

SEC source: 0001140859-24-000085 · wk-form4_1716408514.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 295,843

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:05 UTC GrantCommon Stock 110 $229.20 $25,212.00
Disclosure

SEC source: 0001140859-24-000079 · wk-form4_1714766714.xml · nonDerivative · entry 1

Tyler Lauren M · CIK 0001765744 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,673

F1 · shares: Grant of Restricted Stock Units received in lieu of $25,000 quarterly cash retainer per the Registrant's Non-Employee Director Compensation Program. Delivery of vested shares deferred until 03/01/2025.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:03 UTC GrantCommon Stock 110 $229.20 $25,212.00
Disclosure

SEC source: 0001140859-24-000077 · wk-form4_1714766605.xml · nonDerivative · entry 1

Baumann Werner · CIK 0001986505 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,673

F1 · shares: Grant of Restricted Stock Units received in lieu of $25,000 quarterly cash retainer per the Registrant's Non-Employee Director Compensation Program. Delivery of vested shares deferred until 01/15/2028.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:01 UTC GrantCommon Stock 137 $229.20 $31,400.40
Disclosure

SEC source: 0001140859-24-000075 · wk-form4_1714766495.xml · nonDerivative · entry 1

NALLY DENNIS M · CIK 0001685596 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,956

F1 · shares: Shares of common stock issued in lieu of $31,250 quarterly cash retainer per the terms of the Registrant's Non-Employee Director Compensation Program.

Read SEC document
April 16, 2024 Filed Apr 17, 2024 20:23 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 10,754 $0.00 Strike: $89.58 $0.00
Disclosure

SEC source: 0001140859-24-000060 · wk-form4_1713385377.xml · derivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,545

Underlying: Common Stock · 10,754 shares

Expires 2025-11-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal installments on 11/14/19, 11/14/20, 11/14/21 and 11/14/22.

Read SEC document
April 16, 2024 Filed Apr 17, 2024 20:23 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 10,754 $237.48 $2,553,859.92
Disclosure

SEC source: 0001140859-24-000060 · wk-form4_1713385377.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 285,088

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/18/2023 and disclosed in the Company's Form 8-K filed with the Securities and Exchange Commission on 12/21/2023.

Read SEC document
April 16, 2024 Filed Apr 17, 2024 20:23 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 10,754 $89.58 $963,343.32
Disclosure

SEC source: 0001140859-24-000060 · wk-form4_1713385377.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 295,842

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 20:24 UTC
Mauch Robert P.Executive Vice President & COO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 33,877 $0.00 Strike: $89.58 $0.00
Disclosure

SEC source: 0001140859-24-000062 · wk-form4_1713385480.xml · derivative · entry 3

Mauch Robert P. · CIK 0001633897 · Executive Vice President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 33,877 shares

Expires 2025-11-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Exercisable in four equal annual installments on 11/14/19, 11/14/20, 11/14/21 and 11/14/22.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 20:24 UTC
Mauch Robert P.Executive Vice President & COO
SaleCommon Stock 57,564 $235.09 $13,532,720.76
Disclosure

SEC source: 0001140859-24-000062 · wk-form4_1713385480.xml · nonDerivative · entry 2

Mauch Robert P. · CIK 0001633897 · Executive Vice President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,412

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/19/2023.

F2 · price: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $234.17 to $236.56, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 20:24 UTC
Mauch Robert P.Executive Vice President & COO
Exercise / conversionCommon Stock 33,877 $89.58 $3,034,701.66
Disclosure

SEC source: 0001140859-24-000062 · wk-form4_1713385480.xml · nonDerivative · entry 1

Mauch Robert P. · CIK 0001633897 · Executive Vice President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,976

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 19, 2024 Filed Mar 21, 2024 20:05 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 10,755 $0.00 Strike: $89.58 $0.00
Disclosure

SEC source: 0001140859-24-000058 · wk-form4_1711051512.xml · derivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,299

Underlying: Common Stock · 10,755 shares

Expires 2025-11-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal installments on 11/14/19, 11/14/20, 11/14/21 and 11/14/22.

Read SEC document
March 19, 2024 Filed Mar 21, 2024 20:05 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 10,755 $240.21 $2,583,458.55
Disclosure

SEC source: 0001140859-24-000058 · wk-form4_1711051512.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 285,088

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/18/2023 and disclosed in the Company's Form 8-K filed with the Securities and Exchange Commission on 12/21/2023.

Read SEC document
March 19, 2024 Filed Mar 21, 2024 20:05 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 10,755 $89.58 $963,432.90
Disclosure

SEC source: 0001140859-24-000058 · wk-form4_1711051512.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 295,843

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 18, 2024 Filed Mar 20, 2024 20:23 UTC
Campbell Elizabeth SExecutive Vice President
SaleCommon Stock 6,977 $238.12 $1,661,363.24
Disclosure

SEC source: 0001140859-24-000056 · wk-form4_1710966227.xml · nonDerivative · entry 1

Campbell Elizabeth S · CIK 0001882641 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,246.42

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/15/2023.

Read SEC document
March 18, 2024 Filed May 31, 2024 20:00 UTC
Clark GinaExecutive Vice President
SaleCommon Stock 9,644 $238.12 $2,296,429.28
Disclosure

SEC source: 0001140859-24-000095 · wk-form4_1717185637.xml · nonDerivative · entry 1

Clark Gina · CIK 0001625811 · Executive Vice President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,158

F1 · shares: Sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person effective 12/14/2023.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:33 UTC GrantCommon Stock 843 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000042 · wk-form4_1710361992.xml · nonDerivative · entry 2

HYLE KATHLEEN W · CIK 0001117310 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,406

F2 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:45 UTC GrantCommon Stock 843 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000054 · wk-form4_1710362703.xml · nonDerivative · entry 1

Kim Lorence H. · CIK 0001643746 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,735

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant. Receipt of shares deferred until 03/10/2028.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.